Cardiovascular phenotype in turner syndrome-integrating cardiology, genetics, and endocrinology

Endocrine Reviews

Volumn 33, Issue 5, 2012, Pages 677-714

  Mortensen, Kristian H ^a,b   Andersen, Niels H ^a   Gravholt, Claus H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GROWTH HORMONE; HOMEODOMAIN PROTEIN; NORETHISTERONE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROGESTERONE; RECOMBINANT GROWTH HORMONE; SEX HORMONE; SHOX PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANDROGEN DEFICIENCY; AORTA; AORTA BALLOON; AORTA COARCTATION; AORTA DISSECTION; AORTA RECONSTRUCTION; AORTA VALVE REGURGITATION; AORTIC ROOT SURGERY; AUTOIMMUNITY; BICUSPID AORTIC VALVE; BLOOD CLOTTING; CARDIOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHILDHOOD; CHROMOSOME DELETION; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOCRINE DISEASE; ENDOCRINOLOGY; ESSENTIAL HYPERTENSION; ESTROGEN DEFICIENCY; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ANALYSIS; GENETICS; GENOME IMPRINTING; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HAPLOINSUFFICIENCY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HEREDITY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INFERIOR CAVA VEIN; INFERIOR CAVA VEIN OBSTRUCTION; ISCHEMIC HEART DISEASE; ISOCHROMOSOME; KARYOTYPE; KARYOTYPING; KNOWLEDGE; LIFE EXPECTANCY; LUNG VEIN DRAINAGE ANOMALY; MEDLINE; MEIOSIS; METABOLISM; MITOSIS; MONOSOMY; MORBIDITY; MORTALITY; MOSAICISM; PATHOGENESIS; PATHOPHYSIOLOGY; PERSISTENT ARTERIAL DUCT; PERSISTENT LEFT SUPERIOR VENA CAVA; PHENOTYPE; POLYPLOIDY; POSTOPERATIVE HEMORRHAGE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY VALVE STENOSIS; REVIEW; RING CHROMOSOME; RISK FACTOR; STANDARDIZED MORTALITY RATIO; SYSTEMATIC REVIEW; TURNER SYNDROME; VENOUS THROMBOEMBOLISM; X CHROMOSOME; X CHROMOSOME INACTIVATION; Y CHROMOSOME;

CARDIOVASCULAR DISEASES; FEMALE; GENETIC ASSOCIATION STUDIES; HEART DEFECTS, CONGENITAL; HORMONES; HUMANS; RISK FACTORS; TURNER SYNDROME;

EID: 84870839240     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2011-1059     Document Type: Review

References (357)

1. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. 2006 Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 91:3897-3902
2. Bondy CA. 2007 Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 92:10-25
3. Gravholt CH, Juul S, Naeraa RW, Hansen J. 1998 Morbidity in Turner syndrome. J Clin Epidemiol 51:147-158
4. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. 2008 Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 93:4735-4742
5. Bondy C, Bakalov VK, Lange ED, Ceniceros I. 2006 Deficient medical care for adults with the Turner syndrome. Ann Intern Med 145:866-867
6. Freriks K, Timmermans J, Beerendonk CC, Verhaak CM, Netea-Maier RT, Otten BJ, Braat DD, Smeets DF, Kunst DH, Hermus AR, Timmers HJ. 2011 Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome. J Clin Endocrinol Metab 96:E1517-E1526
7. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, Hultcrantz M, Landin-Wilhelmsen K, Lin A, Lippe B, Pasquino AM, Ranke MB, Rosenfeld R, Silberbach M. 2001 Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 86:3061-3069
8. Gravholt CH. 2004 Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 151: 657-687
9. Lopez L, Arheart KL, Colan SD, Stein NS, Lopez-Mitnik G, Lin AE, Reller MD, Ventura R, Silberbach M. 2008 Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics 121:e1622-e1627
10. Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AF, Jacobs PA. 2005 Mortality and cancer incidence in women with extraXchromosomes: a cohort study in Britain. Hum Genet 118:255-260
11. Price WH, Clayton JF, Collyer S, De Mey R, Wilson J. 1986 Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. J Epidemiol Community Health 40:97-102
12. Mazzanti L, Cacciari E. 1998 Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr 133:688-692
13. HoVB, Bakalov VK, Cooley M, Van PL, HoodMN, Burklow TR, Bondy CA. 2004 Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 110:1694-1700
14. Elsheikh M, Wass JA, Conway GS. 2001 Autoimmune thyroid syndrome in women with Turner's syndrome-the association with karyotype. Clin Endocrinol (Oxf) 55: 223-226
15. Hanson L, Bryman I, Barrenäs ML, Janson PO, Wahlström J, Albertsson-Wikland K, Hanson C. 2001 Genetic analysis of mosaicism in 53 women with Turner syndrome. Hereditas 134:153-159
16. Gravholt CH, Juul S, Naeraa RW, Hansen J. 1996 Prenatal and postnatal prevalence of Turner's syndrome: a registry study. BMJ 312:16-21
17. El-Mansoury M, Barrenäs ML, Bryman I, Hanson C, Larsson C, Wilhelmsen L, Landin-Wilhelmsen K. 2007 Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome. Clin Endocrinol (Oxf) 66:744-751
18. Hagman A, Wennerholm UB, Källén K, Barrenäs ML, Landin-Wilhelmsen K, Hanson C, Bryman I. 2010 Women who gave birth to girls with Turner syndrome: maternal and neonatal characteristics. Hum Reprod 25:1553-1560
19. Warburton D, Kline J, Stein Z, Susser M. 1980 Monosomy X: a chromosomal anomaly associated with young maternal age. Lancet 1:167-169
20. Leichtman DA, Schmickel RD, Gelehrter TD, Judd WJ, Woodbury MC, Meilinger KL. 1978 Familial Turner syndrome. Ann Intern Med 89:473-476
21. Larizza D, Danesino C, Maraschio P, Caramagna C, Klersy C, Calcaterra V. 2011 Familial occurrence of Turner syndrome: casual event or increased risk? J Pediatr Endocrinol Metab 24:223-225
22. Sagi L, Zuckerman-Levin N, Gawlik A, Ghizzoni L, Buyukgebiz A, Rakover Y, Bistritzer T, Admoni O, Vottero A, Baruch O, Fares F, Malecka-Tendera E, Hochberg Z. 2007 Clinical significance of the parental origin of the X chromosome in Turner syndrome. J Clin Endocrinol Metab 92:846-852
23. Stochholm K, Juul S, Gravholt CH. 2010 Mortality and incidence in women with 47,XXX and variants. Am J Med Genet A 152A:367-372
24. Stochholm K, Juul S, Gravholt CH. 2010 Diagnosis and mortality in 47,XYY persons: a registry study. Orphanet J Rare Dis 5:15
25. Held KR, Kerber S, Kaminsky E, Singh S, Goetz P, Seemanova E, Goedde HW. 1992 Mosaicism in 45,X Turner syndrome: does survival in early pregnancy depend on the presence of two sex chromosomes? Hum Genet 88:288-294
26. Fernández R, Méndez J, Pásaro E. 1996 Turner syndrome: a study of chromosomal mosaicism. Hum Genet 98:29-35
27. Hassold TJ. 1986 Chromosome abnormalities in human reproductive wastage. Trends Genet 2:105-110
28. Ross MT, Grafham DV, Coffey AJ, Scherer S, McLay K, Muzny D, Platzer M, Howell GR, Burrows C, Bird CP, Frankish A, Lovell FL, Howe KL, Ashurst JL, Fulton RS, Sudbrak R, WenG, JonesMC, HurlesME, AndrewsTD, Scott CE, Searle S, Ramser J, Whittaker A, Deadman R, Carter NP, Hunt SE, Chen R, Cree A, Gunaratne P, Havlak P, Hodgson A, Metzker ML, Richards S, Scott G, Steffen D, Sodergren E, Wheeler DA, Worley KC, Ainscough R, Ambrose KD, Ansari-Lari MA, et al. 2005 The DNA sequence of the human X chromosome. Nature 434:325-337
29. Lahn BT, Page DC. 1999 Four evolutionary strata on the human X chromosome. Science 286:964-967
30. Yang C, Chapman AG, Kelsey AD, Minks J, Cotton AM, Brown CJ. 2011 X-Chromosome inactivation: molecular mechanisms from the human perspective. Hum Genet 130: 175-185
31. Lyon MF. 1961 Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190:372-373
32. BrownCJ, Lafreniere RG, Powers VE, Sebastio G, Ballabio A, Pettigrew AL, Ledbetter DH, Levy E, Craig IW, Willard HF. 1991 Localization of the X inactivation centre on the human X chromosome in Xq13. Nature 349:82-84
33. Brown CJ, Ballabio A, Rupert JL, Lafreniere RG, Grompe M, Tonlorenzi R, Willard HF. 1991 A gene from the region of the humanXinactivation centre is expressed exclusively from the inactive X chromosome. Nature 349:38-44
34. Jeppesen P, Turner BM. 1993 The inactive X chromosome in female mammals is distinguished by a lack of histoneH4 acetylation, a cytogenetic marker for gene expression. Cell 74:281-289
35. Lee JT, Davidow LS, Warshawsky D. 1999 Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet 21:400-404
36. Heard E, Clerc P, Avner P. 1997 X-chromosome inactivation in mammals. Annu Rev Genet 31:571-610
37. Lyon MF. 2002 X-chromosome inactivation and human genetic disease. Acta Paediatr Suppl 91:107-112
38. Anderson CL, Brown CJ. 1999 Polymorphic X-chromosome inactivation of the human TIMP1 gene. Am J Hum Genet 65:699-708
39. Wareham KA, Lyon MF, Glenister PH, Williams ED. 1987 Age related reactivation of an X-linked gene. Nature 327: 725-727
40. Carrel L, Willard HF. 2005 X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434:400-404
41. Disteche CM, Filippova GN, Tsuchiya KD. 2002 Escape from X inactivation. Cytogenet Genome Res 99:36-43
42. Matura LA, Ho VB, Rosing DR, Bondy CA. 2007 Aortic dilatation and dissection in Turner syndrome. Circulation 116:1663-1670
43. Ober C, Loisel DA, Gilad Y. 2008 Sex-specific genetic architecture of human disease. Nat Rev Genet 9:911-922
44. Wijchers PJ, Yandim C, Panousopoulou E, Ahmad M, Harker N, Saveliev A, Burgoyne PS, Festenstein R. 2010 Sexual dimorphism in mammalian autosomal gene regulation is determined not only by Sry but by sex chromosome complement as well. Dev Cell 19:477-484
45. Xu J, Deng X, Disteche CM. 2008 Sex-specific expression of the X-linked histone demethylase gene Jarid1c in brain. PLoS One 3:e2553
46. Xu J, Deng X, Watkins R, Disteche CM. 2008 Sex-specific differences in expression of histone demethylases Utx and Uty in mouse brain and neurons. J Neurosci 28:4521-4527
47. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA. 1997 Pseudoautosomal deletions encompassing a novelhomeoboxgene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 16:54-63
48. Marchini A, Häcker B, Marttila T, Hesse V, Emons J, Weiss B, Karperien M, Rappold G. 2007 BNP is a transcriptional target of the short stature homeobox gene SHOX. Hum Mol Genet 16:3081-3087
49. Gravholt CH, Hansen KW, Erlandsen M, Ebbehøj E, Christiansen JS. 2006 Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J Hypertens 24:353-360
50. Kosho T, Muroya K, Nagai T, Fujimoto M, Yokoya S, Sakamoto H, Hirano T, Terasaki H, Ohashi H, Nishimura G, Sato S, Matsuo N, Ogata T. 1999 Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab 84:4613-4621
51. Binder G. 2011 Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr 75: 81-89
52. Sachdev V, Matura LA, Sidenko S, HoVB, Arai AE, Rosing DR, Bondy CA. 2008 Aortic valve disease in Turner syndrome. J Am Coll Cardiol 51:1904-1909
53. Li W, Wang X, Fan W, Zhao P, Chan YC, Chen S, Zhang S, Guo X, Zhang Y, Li Y, Cai J, Qin D, Li X, Yang J, Peng T, Zychlinski D, Hoffmann D, Zhang R, Deng K, Ng KM, Menten B, Zhong M, Wu J, Li Z, Chen Y, Schambach A, Tse HF, Pei D, Esteban MA. 2012 Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes. Hum Mol Genet 21:32-45
54. Urbach A, Benvenisty N. 2009 Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells. PLoS One 4:e4175
55. Bondy CA, Ceniceros I, Van PL, Bakalov VK, Rosing DR. 2006 Prolonged rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner syndrome. Pediatrics 118:e1220-e1225
56. Boucher CA, Sargent CA, Ogata T, Affara NA. 2001 Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location. J Med Genet 38:591-598
57. Brandenburg H, Steegers EA, Gittenberger-de Groot AC. 2005 Potential involvement of vascular endothelial growth factor in pathophysiology of Turner syndrome. Med Hypotheses 65:300-304
58. Adachi M, Tachibana K, Asakura Y, Muroya K, Ogata T. 2000 Del(X)(p21.1) in a mother and two daughters: genotype-phenotype correlation of Turner features. Hum Genet 106:306-310
59. Cattanach BM, Kirk M. 1985 Differential activity of maternally and paternally derived chromosome regions in mice. Nature 315:496-498
60. Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M. 1989 Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature 342: 281-285
61. Ko JM, Kim JM, Kim GH, Lee BH, Yoo HW. 2010 Influence of parental origin of the X chromosome on physical phenotypes andGHresponsiveness of patients with Turner syndrome. Clin Endocrinol (Oxf) 73:66-71
62. Van PL, Bakalov VK, Zinn AR, Bondy CA. 2006 Maternal Xchromosome, visceral adiposity, and lipid profile. JAMA 295:1373-1374
63. Chu CE, Donaldson MD, Kelnar CJ, Smail PJ, Greene SA, Paterson WF, Connor JM. 1994 Possible role of imprinting in the Turner phenotype. J Med Genet 31:840-842
64. Cutter WJ, Daly EM, Robertson DM, Chitnis XA, van Amelsvoort TA, Simmons A, Ng VW, Williams BS, Shaw P, Conway GS, Skuse DH, Collier DA, Craig M, Murphy DG. 2006 Influence of X chromosome and hormones on human brain development: a magnetic resonance imaging and proton magnetic resonance spectroscopy study of Turner syndrome. Biol Psychiatry 59:273-283
65. Skuse DH, James RS, Bishop DV, Coppin B, Dalton P, Aamodt-Leeper G, Bacarese-Hamilton M, Creswell C, McGurk R, Jacobs PA. 1997 Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 387:705-708
66. Bondy CA, Matura LA, Wooten N, Troendle J, Zinn AR, Bakalov VK. 2007 The physical phenotype of girls and women with Turner syndrome is not X-imprinted. Hum Genet 121:469-474
67. Mortensen KH, Hjerrild BE, Andersen NH, Sørensen KE, Hørlyck A, Pedersen EM, Lundorf E, Christiansen JS, Gravholt CH. 2010 Abnormalities of the major intrathoracic arteries in Turner syndrome as revealed by magnetic resonance imaging. Cardiol Young 20:191-200
68. Prandstraller D, Mazzanti L, Picchio FM, Magnani C, Bergamaschi R, Perri A, Tsingos E, Cacciari E. 1999 Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 nonpreselected patients. Pediatr Cardiol 20:108-112
69. Völkl TM, Degenhardt K, Koch A, Simm D, Dörr HG, Singer H. 2005 Cardiovascular anomalies in children and young adults with Ullrich-Turner syndrome-the Erlangen experience. Clin Cardiol 28:88-92
70. Andersen NH, Hjerrild BE, Sørensen K, Pedersen EM, Stochholm K, Gormsen LC, Hørlyck A, Christiansen JS, Gravholt CH. 2006 Subclinical left ventricular dysfunction in normotensive women with Turner's syndrome. Heart 92:1516-1517
71. Surerus E, Huggon IC, Allan LD. 2003 Turner's syndrome in fetal life. Ultrasound Obstet Gynecol 22:264-267
72. Gøtzsche CO, Krag-Olsen B, Nielsen J, Sørensen KE, Kristensen BO. 1994 Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 71:433-436
73. Siu SC, Silversides CK. 2010 Bicuspid aortic valve disease. J Am Coll Cardiol 55:2789-2800
74. Kutay V, Yakut C. 2005 Absence of right superior vena cava and aortic annular hypoplasia in a patient with Turner's syndrome. J Card Surg 20:375-376
75. Ostberg JE, Brookes JA, McCarthy C, Halcox J, Conway GS. 2004 A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab 89:5966-5971
76. Schaefer BM, Lewin MB, Stout KK, Gill E, Prueitt A, Byers PH, Otto CM. 2008 The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape. Heart 94:1634-1638
77. Załuska R, Kazłowski J, Gumkowska A, Pikto-Pietkiewicz W. 2008 Congenital disorders of the cardiovascular system and their complications in a 21-year-old woman with Turner syndrome-a case report. Kardiol Pol 66:63-66
78. Cleemann L, Mortensen KH, Holm K, Smedegaard H, Skouby SO, Wieslander SB, Leffers AM, Leth-Espensen P, Pedersen EM, Gravholt CH. 2010 Aortic dimensions in girls and young women with Turner syndrome: a magnetic resonance imaging study. Pediatr Cardiol 31:497-504
79. Hoffman JI, Kaplan S. 2002 The incidence of congenital heart disease. J Am Coll Cardiol 39:1890-1900
80. Dawson-Falk KL, Wright AM, Bakker B, Pitlick PT, WilsonDM, Rosenfeld RG. 1992 Cardiovascular evaluation in Turner syndrome: utility ofMRimaging. Australas Radiol 36:204-209
81. Hjerrild BE, Mortensen KH, Sørensen KE, Pedersen EM, Andersen NH, Lundorf E, Hansen KW, Hørlyck A, Hager A, Christiansen JS, Gravholt CH. 2010 Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study. J Cardiovasc Magn Reson 12:12
82. Mutlu M, Dilber E, Aslan Y, Okten A, Oztürk O. 2010 A Turner syndrome case associated with anal atresia, interrupted aortic arch and multicystic dysplastic kidney. Turk J Pediatr 52:215-217
83. Ravelo HR, Stephenson LW, Friedman S, Chatten J, Rashkind WJ, Vidas M, Edmunds Jr LH. 1980 Coarctation resection in children with Turner's syndrome: a note of caution. J Thorac Cardiovasc Surg 80:427-430
84. Beder SD, Driscoll DJ, McNamara DG, Cooley DA. 1982 Coarctation repair in children with Turner's syndrome. Tex Heart Inst J 9:49-52
85. Brandt 3rd B, Heintz SE, Rose EF, Ehrenhaft JL, Clark EB. 1984 Repair of coarctation of the aorta in children with Turner syndrome. Pediatr Cardiol 5:175-177
86. Zanjani KS, Thanopoulos BD, Peirone A, Alday L, Giannakoulas G. 2010 Usefulness of stenting in aortic coarctation in patients with the Turner syndrome. Am J Cardiol 106:1327-1331
87. Fejzic Z, van Oort A. 2005 Fatal dissection of the descending aorta after implantation of a stent in a 19-year-old female with Turner's syndrome. Cardiol Young 15:529-531
88. Badmanaban B, Mole D, Sarsam MA. 2003 Descending aortic dissection post coarctation repair in a patient with Turner's syndrome. J Card Surg 18:153-154
89. Wu IH, Wu MH, Chen SJ, Wang SS, Chang CI. 2012 Successful deployment of an iliac limb graft to repair acute aortic rupture after balloon aortoplasty of recoarctation in a child with Turner syndrome. Heart Vessels 27:227-230
90. Sybert VP. 1998 Cardiovascular malformations and complications in Turner syndrome. Pediatrics 101:E11
91. Oliver JM, Gallego P, Gonzalez A, Aroca A, Bret M, Mesa JM. 2004 Risk factors for aortic complications in adults with coarctation of the aorta. J AmColl Cardiol 44:1641-1647
92. Kim HK, Gottliebson W, Hor K, Backeljauw P, Gutmark-Little I, Salisbury SR, Racadio JM, Helton-Skally K, Fleck R. 2011 Cardiovascular anomalies in Turner syndrome: spectrum, prevalence, and cardiac MRI findings in a pediatric and young adult population. AJR Am J Roentgenol 196:454-460
93. Eiben B, Bartels I, Bähr-Porsch S, Borgmann S, Gatz G, Gellert G, Goebel R, HammansW, HentemannM, Osmers R, Rauskolb R, Hansmann I. 1990 Cytogenetic analysis of 750 spontaneous abortions with the direct-preparation method of chorionic villi and its implications for studying genetic causes of pregnancy wastage. Am J Hum Genet 47:656-663
94. Miyabara S, Nakayama M, Suzumori K, Yonemitsu N, Sugihara H. 1997 Developmental analysis of cardiovascular system of 45,X fetuses with cystic hygroma. Am J Med Genet 68:135-141
95. Haak MC, Bartelings MM, Gittenberger-De Groot AC, Van Vugt JM. 2002 Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology. Ultrasound Obstet Gynecol 20:14-21
96. Barr Jr M, Oman-Ganes L. 2002 Turner syndrome morphology and morphometrics: cardiac hypoplasia as a cause of midgestation death. Teratology 66:65-72
97. Reis PM, Punch MR, Bove EL, van de Ven CJ. 1999 Outcome of infants with hypoplastic left heart and Turner syndromes. Obstet Gynecol 93:532-535
98. Patel A, Hickey E, Mavroudis C, Jacobs JP, Jacobs ML, Backer CL, Gevitz M, Mavroudis CD. 2010 Impact of noncardiac congenital and genetic abnormalities on outcomes in hypoplastic left heart syndrome. Ann Thorac Surg 89: 1805-1813; discussion 1813-1814
99. van Egmond H, Orye E, Praet M, Coppens M, Devloo-Blancquaert A. 1988 Hypoplastic left heart syndrome and 45X karyotype. Br Heart J 60:69-71
100. Bidot-López P, Matisoff D, Talner NS, Hsia YE. 1978 Hypoplastic left heart in a patient with 45,X/46,XX/47,XXX mosaicism. Am J Med Genet 2:341-343
101. Loscalzo ML, Van PL, Ho VB, Bakalov VK, Rosing DR, Malone CA, Dietz HC, Bondy CA. 2005 Association between fetal lymphedema and congenital cardiovascular defects in Turner syndrome. Pediatrics 115:732-735
102. Nicolaides KH. 2011 Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 31:7-15
103. Allan LD. 2006 The mystery of nuchal translucency. Cardiol Young 16:11-17
104. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. 1999 Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 318:81-85
105. Clark EB. 1984 Neck web and congenital heart defects: a pathogenic association in 45 X-O Turner syndrome? Teratology 29:355-361
106. Hu N, Christensen DA, Agrawal AK, Beaumont C, Clark EB, Hawkins JA. 2009 Dependence of aortic arch morphogenesis on intracardiac blood flow in the left atrial ligated chick embryo. Anat Rec (Hoboken) 292:652-660
107. Berdahl LD, Wenstrom KD, Hanson JW. 1995 Web neck anomaly and its association with congenital heart disease. Am J Med Genet 56:304-307
108. van der Putte SC. 1977 Lymphatic malformation in human fetuses. A study of fetuses with Turner's syndrome or status Bonnevie-Ullrich. Virchows Arch A Pathol Anat Histol 376:233-246
109. Lacro RV, Jones KL, Benirschke K. 1988 Coarctation of the aorta in Turner syndrome: a pathologic study of fetuses with nuchal cystic hygromas, hydrops fetalis, and female genitalia. Pediatrics 81:445-451
110. Goumans MJ, Liu Z, ten Dijke P. 2009 TGF-β signaling in vascular biology and dysfunction. Cell Res 19:116-127
111. Bondy CA. 2008 Congenital cardiovascular disease in Turner syndrome. Congenit Heart Dis 3:2-15
112. Gittenberger-de Groot AC, Azhar M, Molin DG. 2006 Transforming growth factor β-SMAD2 signaling and aortic arch development. Trends Cardiovasc Med 16:1-6
113. Derynck R, Zhang YE. 2003 Smad-dependent and Smadindependent pathways in TGF-β family signalling. Nature 425:577-584
114. Gomez D, Al Haj Zen A, Borges LF, Philippe M, Gutierrez PS, Jondeau G, Michel JB, Vranckx R. 2009 Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol 218:131-142
115. von Kaisenberg CS, Prols F, Nicolaides KH, Maass N, Meinhold-Heerlein I, Brand-Saberi B. 2003 Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency. Hum Reprod 18: 2544-2561
116. Struwe E, Krammer K, Dötsch J, Metzler M, Dörr HG, Cesnjevar R, Rascher W, Koch A. 2006 No evidence for angiotensin type 2 receptor gene polymorphism in intron 1 in patients with coarctation of the aorta and Ullrich-Turner syndrome. Pediatr Cardiol 27:636-639
117. Carmeliet P, Tessier-Lavigne M. 2005 Common mechanisms of nerve and blood vessel wiring. Nature 436:193-200
118. Zuckerman-Levin N, Zinder O, Greenberg A, Levin M, Jacob G, Hochberg Z. 2006 Physiological and catecholamine response to sympathetic stimulation in Turner syndrome. Clin Endocrinol (Oxf) 64:410-415
119. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. 2004 Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25:387-395
120. Fan G, Tran J. 2011 X chromosome inactivation in human and mouse pluripotent stem cells. Hum Genet 130:217-222
121. Bondy CA, Van PL, Bakalov VK, Sachdev V, Malone CA, Ho VB, Rosing DR. 2006 Prolongation of the cardiac QTc interval in Turner syndrome. Medicine (Baltimore) 85: 75-81
122. Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. 2000 Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 52:363-370
123. Gravholt CH, Landin-Wilhelmsen K, Stochholm K, Hjerrild BE, Ledet T, Djurhuus CB, Sylvén L, Baandrup U, Kristensen BØ, Christiansen JS. 2006 Clinical and epidemiological description of aortic dissection in Turner's syndrome. Cardiol Young 16:430-436
124. Olsson C, Thelin S, Ståhle E, Ekbom A, Granath F. 2006 Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation 114:2611-2618
125. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, Evangelista A, Fattori R, Suzuki T, Oh JK, Moore AG, Malouf JF, Pape LA, Gaca C, Sechtem U, Lenferink S, Deutsch HJ, Diedrichs H, Marcos y Robles J, Llovet A, Gilon D, Das SK, Armstrong WF, Deeb GM, Eagle KA. 2000 The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 283:897-903
126. LeMaire SA, Russell L. 2011 Epidemiology of thoracic aortic dissection. Nat Rev Cardiol 8:103-113
127. Carlson M, Silberbach M. 2007 Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature. J Med Genet 44:745-749
128. Apostolopoulos T, Kyriakidis M, Toutouzas P. 1992 Endarteritis of the aortic arch in Turner's syndrome with cystic degeneration of the aorta. Int J Cardiol 35:417-419
129. Lin AE, Lippe B, Rosenfeld RG. 1998 Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics 102:e12
130. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey Jr DE, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, LytleBW, MilewiczDM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. 2010 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/ STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121:e266-e369
131. Prandstraller D, Mazzanti L, Giardini A, Lovato L, Tamburrino F, Scarano E, Cicognani A, Fattori R, Picchio FM. 2009 Correlations of phenotype and genotype in relation to morphologic remodelling of the aortic root in patients with Turner's syndrome. Cardiol Young 19:264-271
132. Elsheikh M, Casadei B, Conway GS, Wass. JA 2001 Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol (Oxf) 54:69-73
133. Lanzarini L, Larizza D, Prete G, Calcaterra V, Meloni G, Sammarchi L, Klersy C. 2007 Aortic dimensions in Turner's syndrome: two-dimensional echocardiography versus magnetic resonance imaging. J Cardiovasc Med (Hagerstown) 8:428-437
134. Mortensen KH, Hjerrild BE, Stochholm K, Andersen NH, Sørensen KE, Lundorf E, Hørlyck A, Pedersen EM, Christiansen JS, Gravholt CH. 2011 Dilation of the ascending aorta in Turner syndrome-a prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 13:24
135. Davies RR, Goldstein LJ, Coady MA, Tittle SL, Rizzo JA, Kopf GS, Elefteriades JA. 2002 Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 73:17-27; discussion 27-28
136. Parish LM, Gorman III JH, Kahn S, Plappert T, St John-Sutton MG, Bavaria JE, Gorman RC. 2009 Aortic size in acute typeAdissection: implications for preventive ascending aortic replacement. Eur J Cardiothorac Surg 35:941-945; discussion 945-946
137. Davies RR, Gallo A, Coady MA, Tellides G, Botta DM, Burke B, Coe MP, Kopf GS, Elefteriades JA. 2006 Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg 81:169-177
138. Burman ED, Keegan J, Kilner PJ. 2008 Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values. Circ Cardiovasc Imaging 1:104-113
139. Coady MA, Rizzo JA, Hammond GL, Kopf GS, Elefteriades JA. 1999 Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications. Ann Thorac Surg 67:1922-1926; discussion 1953-1958
140. Davies RR, Kaple RK, Mandapati D, Gallo A, Botta Jr DM, Elefteriades JA, Coady MA. 2007 Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve. Ann Thorac Surg 83:1338-1344
141. Tzemos N, Therrien J, Yip J, Thanassoulis G, Tremblay S, Jamorski MT, Webb GD, Siu SC. 2008 Outcomes in adults with bicuspid aortic valves. JAMA 300:1317-1325
142. Aronberg DJ, Glazer HS, MadsenK,1; Sagel SS. 1984 Normal thoracic aortic diameters by computed tomography. J Comput Assist Tomogr 8:247-250
143. Baguet JP, Douchin S, Pierre H, Rossignol AM, Bost M, Mallion JM. 2005 Structural and functional abnormalities of large arteries in the Turner syndrome. Heart 91:1442-1446
144. van den Berg J, Bannink EM, Wielopolski PA, Pattynama PM, de Muinck Keizer-Schrama SM, Helbing WA. 2006 Aortic distensibility and dimensions and the effects of growth hormone treatment in the Turner syndrome. Am J Cardiol 97:1644-1649
145. Sharma J, Friedman D, Dave-Sharma S, Harbison M. 2009 Aortic distensibility and dilation in Turner's syndrome. Cardiol Young 19:568-572
146. Bryman I, Sylvén L, Berntorp K, Innala E, Bergström I, Hanson C, Oxholm M, Landin-Wilhelmsen K. 2011 Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil Steril 95:2507-2510
147. Hadnott TN, Gould HN, Gharib AM, Bondy CA. 2011 Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertil Steril 95:2251-2256
148. Karnis MF, Zimon AE, Lalwani SI, Timmreck LS, Klipstein S, Reindollar RH. 2003 Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey. Fertil Steril 80:498-501
149. Chevalier N, Letur H, Lelannou D, Ohl J, Cornet D, Chalas-Boissonnas C, Frydman R, Catteau-Jonard S, Greck-Chassain T, Papaxanthos-Roche A, Dulucq MC, Couet ML, Cédrin-Durnerin I, Pouly JL, Fénichel P. 2011 Materno-fetal cardiovascular complications in Turner syndrome after oocyte donation: insufficient prepregnancy screening and pregnancy follow-up are associated with poor outcome. J Clin Endocrinol Metab 96:E260-E267
150. Bodri D, Vernaeve V, Figueras F, Vidal R, Guillén JJ, Coll O. 2006 Oocyte donation in patients with Turner's syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy. Hum Reprod 21:829-832
151. Foudila T, Söderström-Anttila V, Hovatta O. 1999 Turner's syndrome and pregnancies after oocyte donation. Hum Reprod 14:532-535
152. Bondy C, Rosing D, Reindollar R. 2009 Cardiovascular risks of pregnancy in women with Turner syndrome. Fertil Steril 91:e31-e32
153. Hovatta O. 1999 Pregnancies in women with Turner's syndrome. Ann Med 31:106-110
154. Mortensen KH, Rohde MD, Uldbjerg N, Gravholt CH 2010 Repeated spontaneous pregnancies in 45,X Turner syndrome. Obstet Gynecol 115:446-449
155. ElsheikhM, Dunger DB, Conway GS, Wass JA. 2002 Turner's syndrome in adulthood. Endocr Rev 23:120-140
156. El-Hamamsy I, Yacoub MH. 2009 Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol 6:771-786
157. Humphrey JD. 2008 Mechanisms of arterial remodeling in hypertension: coupled roles of wall shear and intramural stress. Hypertension 52:195-200
158. Della Corte A, Quarto C, Bancone C, Castaldo C, Di Meglio F, Nurzynska D, De Santo LS, De Feo M, Scardone M, Montagnani S, Cotrufo M. 2008 Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix signaling. J Thorac Cardiovasc Surg 135: 8-18, 18.e1-2
159. Cotrufo M, Della Corte A. 2009 The association of bicuspid aortic valve disease with asymmetric dilatation of the tubular ascending aorta: identification of a definite syndrome. J Cardiovasc Med (Hagerstown) 10:291-297
160. Pratt B, Curci J. 2010 Arterial elastic fiber structure. Function and potential roles in acute aortic dissection. J Cardiovasc Surg (Torino) 51:647-656
161. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. 2003 Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407-411
162. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, DeBacker JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC. 2006 Aneurysm syndromes caused by mutations in the TGF-β receptor. N Engl J Med 355:788-798
163. Azhar M, Schultz Jel J, Grupp I, Dorn 2nd GW, Meneton P, Molin DG, Gittenberger-de Groot AC, Doetschman T. 2003 Transforming growth factor β in cardiovascular development and function. Cytokine Growth Factor Rev 14: 391-407
164. He R, Guo DC, Sun W, Papke CL, Duraisamy S, Estrera AL, Safi HJ, Ahn C, Buja LM, Arnett FC, Zhang J, Geng YJ, Milewicz DM. 2008 Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J Thorac Cardiovasc Surg 136:922-929, 929.e1
165. Jørgensen KT, Rostgaard K, Bache I, Biggar RJ, Nielsen NM, Tommerup N, Frisch M.2010 Autoimmune diseases in women with Turner's syndrome. Arthritis Rheum 62: 658-666
166. Mortensen KH, Cleemann L, Hjerrild BE, Nexo E, Locht H, Jeppesen EM, Gravholt CH. 2009 Increased prevalence of autoimmunity in Turner syndrome-influence of age. Clin Exp Immunol 156:205-210
167. Germain DP. 2007 Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis 2:32
168. MilewiczDM, Guo DC, Tran-Fadulu V, Lafont AL, Papke CL, Inamoto S, Kwartler CS, Pannu H. 2008 Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet 9:283-302
169. Haimovici H, Maier N. 1964 Fate of aortic homografts in canine atherosclerosis. 3. Study of fresh abdominal and thoracic aortic implants into thoracic aorta: role of tissue susceptibility in atherogenesis. Arch Surg 89:961-969
170. Castillo C, Cruzado M, Ariznavarreta C, Gil-Loyzaga P, Lahera V, Cachofeiro V, Tresguerres JA. 2005 Effect of recombinant human growth hormone administration on body composition and vascular function and structure in old male Wistar rats. Biogerontology 6:303-312
171. Erikstrup C, Pedersen LM, Heickendorff L, Ledet T, Rasmussen LM. 2001 Production of hyaluronan and chondroitin sulphate proteoglycans from human arterial smooth muscle-the effect of glucose, insulin, IGF-I or growth hormone. Eur J Endocrinol 145:193-198
172. Lombardi G, Galdiero M, Auriemma RS, Pivonello R, Colao A. 2006 Acromegaly and the cardiovascular system. Neuroendocrinology 83:211-217
173. Bondy CA, Van PL, Bakalov VK, Ho VB. 2006 Growth hormone treatment and aortic dimensions in Turner syndrome. J Clin Endocrinol Metab 91:1785-1788
174. Elsheikh M, Bird R, Casadei B, Conway GS, Wass JA. 2000 The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome. J Clin Endocrinol Metab 85:614-618
175. Chan NN, Vallance P, ColhounHM, MacAllister RJ, Hingorani AD, Conway GS. 2002 The effects of hormone replacement therapy on endothelial function in women with Turner's syndrome. Clin Endocrinol (Oxf) 56:615-620
176. Ostberg JE, Storry C, Donald AE, Attar MJ, Halcox JP, Conway GS. 2007 A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol (Oxf) 66:557-564
177. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz III HC. 2008 Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 358:2787-2795
178. Ahimastos AA, Aggarwal A, D'Orsa KM, Formosa MF, White AJ, Savarirayan R, Dart AM, Kingwell BA. 2007 Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA 298:1539-1547
179. Irioka T, Mizusawa H. 2011 Ischemic stroke in a young adult with Turner syndrome. Neurol Sci 32:317-319
180. Finsterer J, Zartl M, Samec P. 2000 Spontaneous cerebral haemorrhage without hypertension in non-mosaic 45X Turner's syndrome. J Clin Neurosci 7:341-343
181. Knisely AS, Sweeney K, Ambler MW. 1988 Pheochromocytoma and sudden death as a result of cerebral infarction in Turner's syndrome: report of a case. J Forensic Sci 33: 1497-1502
182. Spengos K, Kosmaidou-Aravidou Z, Tsivgoulis G, Vassilopoulou S, Grigori-Kostaraki P, Zis V. 2006 Moyamoya syndrome in a Caucasian woman with Turner's syndrome. Eur J Neurol 13:e7-e8
183. Gandhi NN, Hartman ME, Williford WL, Peters MA, Cheifetz IM, Turner DA. 2011 Successful use of extracorporeal membrane oxygenation for pH1N1-induced refractory hypoxemia in a child with hypoplastic left heart syndrome. Pediatr Crit Care Med 12:e398-e401
184. Komori H, Matsuishi T, Abe T, Nagata Y, Ohtaki E, Kojima K, Yukizane S. 1993 Turner syndrome and occlusion of the internal carotid artery. J Child Neurol 8:412-415
185. Rosenblum B, Rothman AS, Lanzieri C, Song S. 1986 A cavernous sinus cavernous hemangioma. Case report. J Neurosurg 65:716-718
186. Muscat P, Lidov M, Nahar T, Tuhrim S, Weinberger J. 2001 Vertebral artery dissection in Turner's syndrome: diagnosis by magnetic resonance imaging. J Neuroimaging 11:50-54
187. Donnan GA, Fisher M, Macleod M, Davis SM. 2008 Stroke. Lancet 371:1612-1623
188. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S. 2010 Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376:112-123
189. Hjerrild BE, Holst JJ, Juhl CB, Christiansen JS, Schmitz O, Gravholt CH. 2011 Delayed β-cell response and glucose intolerance in young women with Turner syndrome. BMC Endocr Disord 11:6
190. Zieske AW, Malcom GT, Strong JP. 2002 Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med 21:213-237
191. Nilsson PM, Lurbe E, Laurent S. 2008 The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens 26:1049-1057
192. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. 1989 Weight in infancy and death from ischaemic heart disease. Lancet 2:577-580
193. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, Barrett-Connor E, Bhargava SK, Birgisdottir BE, Carlsson S, de Rooij SR, Dyck RF, Eriksson JG, Falkner B, Fall C, Forsén T, Grill V, Gudnason V, Hulman S, Hyppönen E, Jeffreys M, Lawlor DA, Leon DA, Minami J, Mishra G, Osmond C, Power C, Rich-Edwards JW, Roseboom TJ, Sachdev HS, Syddall H, Thorsdottir I, Vanhala M, Wadsworth M, Yarbrough DE. 2008 Birth weight and risk of type 2 diabetes: a systematic review. JAMA 300:2886-2897
194. Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. 2006 Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocr Rev 27:575-605
195. Colao A. 2008 The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin Endocrinol (Oxf) 69: 347-358
196. Ostberg JE, Donald AE, Halcox JP, Storry C, McCarthy C, Conway GS. 2005 Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab 90:5161-5166
197. Van Bortel LM. 2005 What does intima-media thickness tell us? J Hypertens 23:37-39
198. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, OlsenMH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A. 2009 Reappraisal of European guidelines on hyperten-sion management: a European Society of Hypertension Task Force document. J Hypertens 27:2121-2158
199. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. 2007 Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459-467
200. Pirgon O, Atabek ME, Oran B, Gü çlü R. 2008 Atherogenic lipid profile and systolic blood pressure are associated with carotid artery intima-media thickness in children with Turner syndrome. J Clin Res Pediatr Endocrinol 1:62-71
201. Gravholt CH, Mortensen KH, Andersen NH, Ibsen L, Ingerslev J, Hjerrild BE. 2012 Coagulation and fibrinolytic disturbances are related to carotid intima thickness and arterial blood pressure in Turner syndrome. Clin Endocrinol (Oxf) 76:649-656
202. LorenzMW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. 2006 Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 37:87-92
203. Mortensen KH, Hansen KW, Erlandsen M, Christiansen JS, Gravholt CH. 2009 Ambulatory arterial stiffness index in Turner syndrome: the impact of sex hormone replacement therapy. Horm Res 72:184-189
204. Fuentes K, Silveira DC, Papamitsakis NI. 2007 Spontaneous carotid artery dissection in a patient with Turner syndrome. Cerebrovasc Dis 24:543-544
205. Jagannath AD, Rastogi U, Spooner AE, Lin AE, Agnihotri AK. 2010 Aortic dissection and moyamoya disease in Turner syndrome. Am J Med Genet A 152A:2085-2089
206. LancmanM, Mesropian H, Serra P, Granillo R. 1991 Turner's syndrome, fibromuscular dysplasia, and stroke. Stroke 22:269-271
207. Olin JW, Sealove BA. 2011 Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg 53:826-836.e1
208. Scott RM, Smith ER. 2009 Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226-1237
209. Grond-Ginsbach C, Pjontek R, Aksay SS, Hyhlik-Dü rr A, Böckler D, Gross-Weissmann ML. 2010 Spontaneous arterial dissection: phenotype and molecular pathogenesis. Cell Mol Life Sci 67:1799-1815
210. Klein LW, Levin JL, Weintraub WS, Agarwal JB, Helfant RH. 1984 Pseudocoarctation of the aortic arch in a patient with Turner's syndrome. Clin Cardiol 7:621-623
211. De Filippo P, Colombo S, Brambilla R, Borghi A, Cantu' F. 2008 Ablation of atrial tachycardia from a giant left superior vena cava using integration with computed tomographic imaging. Circ Arrhythm Electrophysiol 1:143-144
212. Landin-Wilhelmsen K, Bryman I, Wilhelmsen L. 2001 Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab 86:4166-4170
213. Sozen AB, Cefle K, Kudat H, Ozturk S, Oflaz H, Pamukcu B, Akkaya V, Isguven P, Palanduz S, Ozcan M, Goren T, Guven O. 2008 Atrial and ventricular arryhthmogenic potential in Turner syndrome. Pacing Clin Electrophysiol 31: 1140-1145
214. Dilaveris PE, Gialafos JE. 2001 P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 6:159-165
215. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P, Vardas PE, Agladze V, Aliot E, Balabanski T, Blomstrom-Lundqvist C, Capucci A, Crijns H, Dahlöf B, Folliguet T, GliksonM, GoethalsM, Gulba DC, HoSY, Klautz RJ, Kose S, McMurray J, Perrone Filardi P, Raatikainen P, Salvador MJ, Schalij MJ, Shpektor A, Sousa J, Stepinska J, Uuetoa H, Zamorano JL, Zupan I. 2010 Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:1360-1420
216. Bakiler AR, Cangar S, Aksit S, Unver A, Yaprak I, Caglayan S. 1993 Disappearing intracardiac thrombi in both atria after mumps in a patient with Turner syndrome. Chest 103:1611-1612
217. Ferro JM, Massaro AR, Mas JL. 2010 Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol 9:1085-1096
218. Witt BJ, Gami AS, Ballman KV, Brown Jr RD, Meverden RA, Jacobsen SJ, Roger VL. 2007 The incidence of ischemic stroke in chronic heart failure: a meta-analysis. J Card Fail 13:489-496
219. Lanes R, Gunczler P, Palacios A, Villaroel O. 1997 Serum lipids, lipoprotein lp (a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy. Fertil Steril 68: 473-477
220. Calcaterra V, GambaG, Montani N, de Silvestri A, Terulla V, Lanati G, Larizza D. 2011 Thrombophilic screening in Turner syndrome. J Endocrinol Invest 34:676-679
221. Kelsey G, Monagle P, Barnes C. 2006 Delayed diagnosis of congenital factor IX deficiency (Christmas disease) in a girl with Turner's syndrome. Clin Lab Haematol 28:355-356
222. Weinspach S, Siepermann M, Schaper J, Sarikaya-Seiwert S, Rieder H, Gerigk M, Höhn T, Laws HJ. 2009 Intracranial hemorrhage in a female leading to the diagnosis of severe hemophilia A and Turner syndrome. Klin Padiatr 221:167-171
223. Aligeti VR, Horn HR. 2007 Turner's syndrome and coronary artery disease. Am J Cardiol 99:741-742
224. Gerlis LM, Gatzoulis M, Ho SY, Sheppard MN. 2004 Sudden unexpected cardiac death in a patient with Turner's syndrome. Cardiol Young 14:192-196
225. Garvey P, Elovitz M, Landsberger EJ. 1998 Aortic dissection and myocardial infarction in a pregnant patient with Turner syndrome. Obstet Gynecol 91:864
226. Kalin MF, Zumoff B. 1990 Sex hormones and coronary disease: a review of the clinical studies. Steroids 55:330-352
227. Salgin B, Amin R, Yuen K, Williams RM, Murgatroyd P, Dunger DB. 2006 Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome. Horm Res 65:69-75
228. Kozlowska-Wojciechowska M, Jez W, Zdrojewski T, Chwojnicki K. 2006 Are young women with Turner syndrome at greater risk of coronary artery disease? Eur J Cardiovasc Prev Rehabil 13:467-469
229. Hjerrild BE, Mortensen KH, Gravholt CH. 2008 Turner syndrome and clinical treatment. Br Med Bull 86:77-93
230. Polkampally PR, Matta JR, McAreavey D, Bakalov V, Bondy CA, Gharib AM. 2011 Aneurysmal dilatation of medium caliber arteries in Turner syndrome. Congenit Heart Dis 6:382-383
231. Oohara K, Yamazaki T, Sakaguchi K, Nakayama M, Kobayashi A. 1995 Acute aortic dissection, aortic insufficiency, and a single coronary artery in a patient with Turner's syndrome. J Cardiovasc Surg (Torino) 36:273-275
232. Forgosh LB, Conetta DA. 1992 Cardiac assessment in Turner's syndrome: a case for the inclusion of coronary angiography. J Am Soc Echocardiogr 5:281-284
233. Luckraz H, Mohammed A, Youhana A. 2006 A prominent collateral coronary artery. Ann Thorac Surg 81:1518
234. Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, Christiansen JS. 1998 Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 21:1062-1070
235. Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. 2000 The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome. Clin Endocrinol (Oxf) 52:371-377
236. Virdis R, Cantu MC, Ghizzoni L, Ammenti A, Nori G, Volta C, Cravidi C, Vanelli M, Balestrazzi P, Bernasconi S, Giovannelli G. 1986 Blood pressure behaviour and control in Turner syndrome. Clin Exp Hypertens A 8:787-791
237. Radetti G, Crepaz R, Milanesi O, Paganini C, Cesaro A, Rigon F, Pitscheider W. 2001 Cardiac performance in Turner's syndrome patients on growth hormone therapy. Horm Res 55:240-244
238. Jelić S, Marisavljević D. 1997 [Turner's syndrome with mosaic karyotype and renovascular hypertension]. Srp Arh Celok Lek 125:48-50
239. Boldo A, White WB. 2011 Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies. Endocrinol Metab Clin North Am 40:419-432, ix
240. Giordano R, Forno D, Lanfranco F, Manieri C, Ghizzoni L, Ghigo E. 2011 Metabolic and cardiovascular outcomes in a group of adult patients with Turner's syndrome under hormonal replacement therapy. Eur J Endocrinol 164: 819-826
241. Komukai K, Mochizuki S, YoshimuraM2010 Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol 24:687-698
242. Langrish JP, Mills NL, Bath LE, Warner P, Webb DJ, Kelnar CJ, Critchley HO, Newby DE, WallaceWH2009 Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 53:805-811
243. Caprio S, Boulware S, DiamondM, Sherwin RS, Carpenter TO, Rubin K, Amiel S, Press M, Tamborlane WV 1991 Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 72:832-836
244. Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, Sullivan G, Bondy CA. 2004 Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 89:3516-3520
245. Gravholt CH, Hjerrild BE, Mosekilde L, Hansen TK, Rasmussen LM, Frystyk J, Flyvbjerg A, Christiansen JS. 2006 Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol 155: 583-592
246. Ostberg JE, Attar MJ, Mohamed-Ali V, Conway GS. 2005 Adipokine dysregulation in Turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein. J Clin Endocrinol Metab 90:2948-2953
247. Eriksson JG, Forsén TJ, Kajantie E, Osmond C, Barker DJ. 2007 Childhood growth and hypertension in later life. Hypertension 49:1415-1421
248. Baldin AD, Siviero-Miachon AA, Fabbri T, de Lemos-Marini SH, Spinola-Castro AM, Baptista MT, D'Souza-Li LF, Morcillo AM, Maciel-Guerra AT, Guerra-Junior G. 2012 Turner syndrome and metabolic derangements: another example of fetal programming. Early Hum Dev 88: 99-102
249. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. 2008 The metabolic syndrome. Endocr Rev 29:777-822
250. Tanous D, Benson LN, Horlick EM. 2009 Coarctation of the aorta: evaluation and management. Curr Opin Cardiol 24:509-515
251. Okuno S, Nishi N, Sakaki T. 2005 Putaminal hemorrhage in a case of Turner's syndrome with hyperaldosteronemia. No Shinkei Geka 33:171-176
252. Lippe B, GeffnerME, Dietrich RB, Boechat MI, Kangarloo H. 1988 Renal malformations in patients with Turner syndrome: imaging in 141 patients. Pediatrics 82:852-856
253. Liao AW, Snijders R, Geerts L, Spencer K, Nicolaides KH. 2000 Fetal heart rate in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol 16:610-613
254. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, Levy D. 2000 Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 86:309-312
255. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. 2004 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937-952
256. Kannel WB. 2000 Vital epidemiologic clues in heart failure. J Clin Epidemiol 53:229-235
257. Mancia G, DeBacker G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B. 2007 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105-1187
258. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. 2006 Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117-121
259. Ong KT, Perdu J, De Backer J, Bozec E, Collignon P, Emmerich J, Fauret AL, Fiessinger JN, Germain DP, Georgesco G, Hulot JS, De Paepe A, Plauchu H, Jeunemaitre X, Laurent S, Boutouyrie P. 2010 Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet 376:1476-1484
260. Berg KA, Clark EB, Astemborski JA, Boughman JA. 1988 Prenatal detection of cardiovascular malformations by echocardiography: an indication for cytogenetic evaluation. Am J Obstet Gynecol 159:477-481
261. Tancredi G, Versacci P, Pasquino AM, Vittucci AC, Pucarelli I, Cappa M, Di Mambro C, Marino B. 2011 Cardiopulmonary response to exercise and cardiac assessment in patients with Turner syndrome. Am J Cardiol 107: 1076-1082
262. Golzio PG, Franco E, Chiribiri A. 2006 Atrio-ventricular synchronization by single VDD lead inserted through persistent left superior vena cava in patient with Turner's syndrome. Pacing Clin Electrophysiol 29:1181-1182
263. Kannel WB, Kannel C, Paffenbarger Jr RS, Cupples LA. 1987 Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113:1489-1494
264. Roden DM. 2008 Clinical practice. Long-QT syndrome. N Engl J Med 358:169-176
265. Dalla Pozza R, Bechtold S, Kääb S, Buckl M, Urschel S, Netz H, Schwarz HP. 2006 QTc interval prolongation in children with Ulrich-Turner syndrome. Eur J Pediatr 165: 831-837
266. Bokil NJ, Baisden JM, Radford DJ, Summers KM. 2010 Molecular genetics of long QT syndrome. Mol Genet Metab 101:1-8
267. Blaschke RJ, Rappold GA. 2001 SHOX in short stature syndromes. Horm Res 55(Suppl 1):21-23
268. Davenport ML. 2010 Approach to the patient with Turner syndrome. J Clin Endocrinol Metab 95:1487-1495
269. Westwood M, Tajbakhsh SH, Siddals KW, Whatmore AJ, Clayton PE. 2011 Reduced pericellular sensitivity to IGF-I in fibroblasts from girls with Turner syndrome: a mechanism to impair clinical responses to GH. Pediatr Res 70: 25-30
270. Whatmore AJ, Patel L, Clayton PE. 2009 A pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response toGHtreatment. Clin Endocrinol (Oxf) 70:429-434
271. Lin TH, Kirkland JL, Kirkland RT. 1988 Growth hormone assessment and short-term treatment with growth hormone in Turner syndrome. J Pediatr 112:919-922
272. Massarano AA, Brook CG, Hindmarsh PC, Pringle PJ, Teale JD, Stanhope R, Preece MA. 1989 Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol. Arch Dis Child 64:587-592
273. Zadik Z, Landau H, Chen M, Altman Y, Lieberman E. 1992 Assessment of growth hormone (GH) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation. J Clin EndocrinolMetab75:412-416
274. Wit JM, Massarano AA, KampGA, Hindmarsh PC, van Es A, Brook CG, Preece MA, Matthews DR. 1992 Growth hormone secretion in patients with Turner's syndrome as determined by time series analysis. Acta Endocrinol (Copenh) 127:7-12
275. Lanes R, Brito S, Suniaga M, Moncada G, Borges M. 1990 Growth hormone secretion in pubertal age patients with Turner's syndrome. J Clin Endocrinol Metab 71:770-772
276. Gravholt CH, Naeraa RW, Fisker S, Christiansen JS. 1997 Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 β-estradiol. J Clin Endocrinol Metab 82:2570-2577
277. Foster CM, Borondy M, Markovs ME, Hopwood NJ, Kletter GB, Beitins IZ. 1994 Growth hormone bioactivity in girls with Turner's syndrome: correlation with IGF-I. Pediatr Res 35:218-222
278. Gravholt CH, Frystyk J, Flyvbjerg A, Orskov H, Christiansen JS. 2001 Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids. Am J Physiol Endocrinol Metab 280:E308-E314
279. Gravholt CH, Chen JW, Oxvig C, Overgaard MT, Christiansen JS, Frystyk J, Flyvbjerg A. 2006 The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT. Growth Horm IGF Res 16:332-339
280. Ross JL, Quigley CA, Cao D, Feuillan P, Kowal K, Chipman JJ, Cutler Jr GB. 2011 Growth hormone plus childhood low-dose estrogen in Turner's syndrome. N Engl J Med 364:1230-1242
281. Stephure DK. 2005 Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 90:3360-3366
282. Stochholm K, Laursen T, Green A, Laurberg P, Andersen M, Kristensen LØ, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Gravholt CH. 2008 Morbidity and GH deficiency: a nationwide study. Eur J Endocrinol 158:447-457
283. Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM. 2010 Mortality in patients with pituitary disease. Endocr Rev 31:301-342
284. Johnsen SP, Hundborg HH, Sørensen HT, Orskov H, Tjønneland A, Overvad K, Jørgensen JO. 2005 Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 90:5937-5941
285. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T. 2002 Low serum IGF-I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106:939-944
286. GravholtCH, Veldhuis JD, Christiansen JS. 1998 Increased disorderliness and decreased mass and daily rate of endogenous growth hormone secretion in adult Turner syndrome: the impact of body composition, maximal oxygen uptake and treatment with sex hormones. Growth Horm IGF Res 8:289-298
287. Bengtsson BA, Edén S, Ernest I, Odén A, Sjögren B. 1988 Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327-335
288. Colao A, Vitale G, Pivonello R, Ciccarelli A, di SC, Lombardi G. 2004 The heart: an end-organ of GH action. Eur J Endocrinol 151(Suppl 1):S93-S101
289. Matura LA, Sachdev V, Bakalov VK, Rosing DR, Bondy CA. 2007 Growth hormone treatment and left ventricular dimensions in Turner syndrome. J Pediatr 150:587-591
290. Bolar K, Hoffman AR, Maneatis T, Lippe B. 2008 Longterm safety of recombinant human growth hormone in Turner syndrome. J Clin Endocrinol Metab 93:344-351
291. Bannink EM, van der Palen RL, Mulder PG, de Muinck Keizer-Schrama SM. 2009 Long-term follow-up of GHtreated girls with Turner syndrome: BMI, blood pressure, body proportions. Horm Res 71:336-342
292. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Aanstoot HJ, Drop SL. 2000 Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone. J Clin Endocrinol Metab 85:769-775
293. Menke LA, Sas TC, Stijnen T, Zandwijken GR, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM. 2011 Effect of oxandrolone on glucose metabolism in growth hormonetreated girls with Turner syndrome. Horm Res Paediatr 75:115-122
294. Gravholt CH, Naeraa RW, Brixen K, Kastrup KW, Mosekilde L, Jørgensen JO, Christiansen JS. 2002 Shortterm growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics 110:889-896
295. Querfeld U, Döpper S, Gradehand A, Kiencke P, Wahn F, Zeisel HJ. 1999 Long-term treatment with growth hormone has no persisting effect on lipoprotein (a) in patients with Turner's syndrome. J Clin Endocrinol Metab 84:967-970
296. van Teunenbroek A, de Muinck Keizer-Schrama SM, Aanstoot HJ, Stijnen T, Hoogerbrugge N, Drop SL. 1999 Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome. Dutch Working Group on Growth Hormone. Metabolism 48:7-14
297. Wooten N, Bakalov VK, Hill S, Bondy CA. 2008 Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. J Clin Endocrinol Metab 93:2109-2114
298. Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. 1997 Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. J Clin Endocrinol Metab 82:1810-1813
299. Borgström B, Birgit B, Hreinsson J, Julius H, Rasmussen C, Carsten R, Sheikhi M, Maryam S, Fried G, Gabriel F, Keros V, Victoria K, Fridström M, Margareta F, Hovatta O, Outi H. 2009 Fertility preservation in girls with Turner syndrome: prognostic signs of the presence of ovarian follicles. J Clin Endocrinol Metab 94:74-80
300. Modi DN, Sane S, Bhartiya D. 2003 Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol Hum Reprod 9:219-225
301. Gupta S, Chiplunkar S, Gupta A, Gollapudi S. 2003 Increased spontaneous, tumor necrosis factor receptor- and CD95 (Fas)-mediated apoptosis in cord blood T-cell subsets from Turner's syndrome. Genes Immun 4:239-243
302. Modi D, Sane S, Bhartiya D. 2009 Over-expression of Mullerian inhibiting substancemRNAin the Turner syndrome ovary. Sex Dev 3:245-252
303. van ParerenYK, deMuinckKeizer-SchramaSM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwé CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL. 2003 Final height in girls with Turner syndrome after longterm growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 88:1119-1125
304. Løkkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT. 2006 The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas 53:226-233
305. Maclaran K, Horner E, Panay N. 2010 Premature ovarian failure: long-term sequelae. Menopause Int 16:38-41
306. Mendelsohn ME, Karas RH. 2005 Molecular and cellular basis of cardiovascular gender differences. Science 308: 1583-1587
307. Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. 2008 Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 336:1227-1231
308. HelmerhorstFM, BloemenkampKW, Rosendaal FR, Vandenbroucke JP. 1997 Oral contraceptives and thrombotic disease: risk of venous thromboembolism. Thromb Haemost 78:327-333
309. Papagianni V, Deligeoroglou E, Makrakis E, Botsis D, Creatsas G. 2011 Response to hormonal treatment of young females with primary or very premature ovarian failure. Gynecol Endocrinol 27:291-299
310. Taboada M, Santen R, Lima J, Hossain J, Singh R, Klein KO, Mauras N. 2011 Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome. J Clin Endocrinol Metab 96:3502-3510
311. Schumacher M, Guennoun R, Ghoumari A, Massaad C, Robert F, El-Etr M, Akwa Y, Rajkowski K, Baulieu EE. 2007 Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev 28:387-439
312. Høst C, Bojesen A, Frystyk J, Flyvbjerg A, Christiansen JS, Gravholt CH. 2010 Effect of sex hormone treatment on circulating adiponectin and subforms in Turner and Klinefelter syndrome. Eur J Clin Invest 40:211-219
313. Apter D, Lenko HL, Perheentupa J, Söderholm A, VihkoR. 1982 Subnormal pubertal increases of serum androgens in Turner's syndrome. Horm Res 16:164-173
314. Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J. 1999 Reduced androgen levels in adult Turner syndrome: influence of female sex steroids and growth hormone status. Clin Endocrinol (Oxf) 50:791-800
315. Martin DD, Schweizer R, Schwarze CP, Elmlinger MW, Ranke MB, Binder G. 2004 The early dehydroepiandrosterone sulfate rise of adrenarche and the delay of pubarche indicate primary ovarian failure in Turner syndrome. J Clin Endocrinol Metab 89:1164-1168
316. Zuckerman-Levin N, Frolova-Bishara T, Militianu D, Levin M, Aharon-Peretz J, Hochberg Z. 2009 Androgen replacement therapy in Turner syndrome: a pilot study. J Clin Endocrinol Metab 94:4820-4827
317. Davis SR, Burger HG. 2003 The role of androgen therapy. Best Pract Res Clin Endocrinol Metab 17:165-175
318. Wilson DM, Frane JW, Sherman B, Johanson AJ, Hintz RL, Rosenfeld RG. 1988 Carbohydrate and lipid metabolism in Turner syndrome: effect of therapy with growth hormone, oxandrolone, and a combination of both. J Pediatr 112:210-217
319. Haeusler G, Schmitt K, Blümel P, Plöchl E, Waldhör T, Frisch H. 1996 Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone. J Clin Endocrinol Metab 81:536-541
320. Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarrevan de Waal HA, Stokvis-BrantsmaWH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM. 2010 Efficacy and safety of oxandrolone in growth hormone-treated girls with Turner syndrome. J Clin Endocrinol Metab 95:1151-1160
321. Gault EJ, Perry RJ, Cole TJ, Casey S, Paterson WF, Hindmarsh PC, Betts P, Dunger DB, Donaldson MD. 2011 Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial. BMJ 342:d1980
322. Holl RW, Kunze D, Etzrodt H, Teller W, Heinze E. 1994 Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients. Eur J Pediatr 153:11-16
323. Polychronakos C, Letarte J, Collu R, Ducharme JR. 1980 Carbohydrate intolerance in children and adolescents with Turner syndrome. J Pediatr 96:1009-1014
324. Cicognani A, Mazzanti L, Tassinari D, Pellacani A, Forabosco A, Landi L, Pifferi C, Cacciari E. 1988 Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Eur J Pediatr 148:64-68
325. Stoppoloni G, Prisco F, Alfano C, Iafusco D, Marrazzo G, Paolisso G. 1990 Characteristics of insulin resistance in Turner syndrome. Diabete Metab 16:267-271
326. Heinze E, Schlickenrieder J, Holl RW, Ebert R. 1991 Reduced secretion of gastric inhibitory polypeptide in Turner patients with impaired glucose tolerance. Eur J Pediatr 150:339-342
327. Bakalov VK, Cheng C, Zhou J, Bondy CA. 2009 X-Chromosome gene dosage and the risk of diabetes in Turner syndrome. J Clin Endocrinol Metab 94:3289-3296
328. Gravholt CH, Leth-Larsen R, Lauridsen AL, Thiel S, Hansen TK, Holmskov U, Naeraa RW, Christiansen JS. 2004 The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome. Eur J Endocrinol 150:355-362
329. Greising SM, Baltgalvis KA, Lowe DA, Warren GL. 2009 Hormone therapy and skeletal muscle strength: a metaanalysis. J Gerontol A Biol Sci Med Sci 64:1071-1081
330. Gravholt CH, Nyholm B, Saltin B, Schmitz O, Christiansen JS. 2001 Muscle fiber composition and capillary density in Turner syndrome: evidence of increased muscle fiber size related to insulin resistance. Diabetes Care 24:1668-1673
331. Livingstone C, Collison M. 2002 Sex steroids and insulin resistance. Clin Sci (Lond) 102:151-166
332. Godsland IF. 2005 Oestrogens and insulin secretion. Diabetologia 48:2213-2220
333. Barros RP, Gustafsson JA. 2011 Estrogen receptors and the metabolic network. Cell Metab 14:289-299
334. El-Mansoury M, Berntorp K, Bryman I, Hanson C, Innala E, Karlsson A, Landin-Wilhelmsen K. 2008 Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. Clin Endocrinol (Oxf) 68:485-490
335. ElsheikhM, Hodgson HJ, WassJA, Conway GS. 2001 Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clin Endocrinol (Oxf) 55:227-231
336. Roulot D, Degott C, Chazouille'res O, Oberti F, Cale's P, Carbonell N, Benferhat S, Bresson-Hadni S, Valla D. 2004 Vascular involvement of the liver in Turner's syndrome. Hepatology 39:239-247
337. Gravholt CH, Poulsen HE, Ott P, Christiansen JS, Vilstrup H. 2007 Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. Eur J Endocrinol 156:679-686
338. Koulouri O, Ostberg J, Conway GS. 2008 Liver dysfunction in Turner's syndrome: prevalence, natural history and effect of exogenous oestrogen. Clin Endocrinol (Oxf) 69: 306-310
339. El-Mansoury M, Bryman I, Berntorp K, Hanson C, Wilhelmsen L, Landin-Wilhelmsen K. 2005 Hypothyroidism is common in Turner syndrome: results of a five-year followup. J Clin Endocrinol Metab 90:2131-2135
340. Klein I, Danzi S. 2007 Thyroid disease and the heart. Circulation 116:1725-1735
341. Pernis AB. 2007 Estrogen and CD4+ T cells. Curr Opin Rheumatol 19:414-420
342. Straub RH. 2007 The complex role of estrogens in inflammation. Endocr Rev 28:521-574
343. Blaschke RJ, Rappold G. 2006 The pseudoautosomal regions, SHOX and disease. Curr Opin Genet Dev 16:233-239
344. Joseph M, Cantú ES, Pai GS, Willi SM, Papenhausen PR, Weiss L. 1996 Xp pseudoautosomal gene haploinsufficiency and linear growth deficiency in three girls with chro-mosome Xp22;Yq11 translocation. J Med Genet 33:906-911
345. Kveiborg M, Gravholt CH, Kassem M. 2001 Evidence of a normal mean telomere fragment length in patients with Ullrich-Turner syndrome. Eur J Hum Genet 9:877-879
346. Güngör N, Böke B, Belgin E, Tunçbilek E. 2000 High frequency hearing loss in Ullrich-Turner syndrome. Eur J Pediatr 159:740-744
347. Vriend JW, Mulder BJ. 2005 Late complications in patients after repair of aortic coarctation: implications for management. Int J Cardiol 101:399-406
348. Januzzi JL, Sabatine MS, Eagle KA, Evangelista A, Bruckman D, Fattori R, OhJK, Moore AG, Sechtem U, Llovet A, Gilon D, Pape L, O'Gara PT, Mehta R, Cooper JV, Hagan PG, Armstrong WF, Deeb GM, Suzuki T, Nienaber CA, Isselbacher EM. 2002 Iatrogenic aortic dissection. Am J Cardiol 89:623-626
349. Richens D, Kotidis K, Neale M, Oakley C, Fails A. 2003 Rupture of the aorta following road traffic accidents in the United Kingdom 1992-1999. The results of the co-operative crash injury study. Eur J Cardiothorac Surg 23:143-148
350. Jobe S, Donohoue P, Di Paola J. 2004 Deep venous thrombosis and Turner syndrome. J Pediatr Hematol Oncol 26: 272
351. Donal E, Coisne D, Corbi P. 2000 Images in cardiology: a case report of aortic arch mobile thrombi. Heart 84:614
352. Kopacek Zilz C, Keller Brenner J, Elnecave RH. 2006 Portal vein thrombosis and high factor VIII in Turner syndrome. Horm Res 66:89-93
353. Ureten K, Ozturk MA, Bostanci A, Ceneli O, Ozbek M, Haznedaroglu IC. 2010 Atraumatic osteonecrosis after estrogen replacement therapy associated with low protein S level in a patient with Turner syndrome. Clin Appl Thromb Hemost 16:599-601
354. Pinto RB, Silveira TR, Bandinelli E, Röhsig L. 2004 Portal vein thrombosis in children and adolescents: the low prevalence of hereditary thrombophilic disorders. J Pediatr Surg 39:1356-1361
355. Sozen AB, Cefle K, Kudat H, Ozturk S, Oflaz H, Akkaya V, Palanduz S, Demirel S, Ozcan M, Goren T, Guven O. 2009 Left ventricular thickness is increased in nonhypertensive Turner's syndrome. Echocardiography 26:943-949
356. Sas TC, Cromme-Dijkhuis AH, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Drop SL. 1999 The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner's syndrome. Dutch Working Group on Growth Hormone. J Pediatr 135:470-476
357. van den Berg J, Bannink EM, Wielopolski PA, Hop WC, van Osch-Gevers L, Pattynama PM, de Muinck Keizer-Schrama SM, Helbing WA. 2008 Cardiac status after childhood growth hormone treatment of Turner syndrome. J Clin Endocrinol Metab 93:2553-2558